A Prospective, Randomized, Investigator-Blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) Vs Menopure (Ferring) Administered s.c. [subcutaneously] in Women Undergoing COH [controlled ovarian hyperstimulation] in an ART Programme (IVF) [in vitro fertilisation]

Trial Profile

A Prospective, Randomized, Investigator-Blind, Controlled, Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA (IBSA) Vs Menopure (Ferring) Administered s.c. [subcutaneously] in Women Undergoing COH [controlled ovarian hyperstimulation] in an ART Programme (IVF) [in vitro fertilisation]

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Menotropin (Primary)
  • Indications Infertility
  • Focus Therapeutic Use
  • Acronyms ART-Programme
  • Sponsors IBSA
  • Most Recent Events

    • 17 Dec 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 17 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top